- 2-aminobenzimidazoles for leishmaniasis: From initial hit discovery to in vivo profiling
-
Leishmaniasis is a major infectious disease with hundreds of thousands of new cases and over 20,000 deaths each year. The current drugs to treat this life-threatening infection have several drawbacks such as toxicity and long treatment regimens. A library of 1.8 million compounds, from which the hits reported here are publicly available, was screened against Leishmania infantum as part of an optimization program; a compound was found with a 2-aminobenzimidazole functionality presenting moderate potency, low metabolic stability and high lipophilicity. Several rounds of synthesis were performed to incorporate chemical groups capable of reducing lipophilicity and clearance, leading to the identification of compounds that are active against different parasite strains and have improved in vitro proper-ties. As a result of this optimization program, a group of compounds was further tested in anticipation of in vivo evaluation. In vivo tests were carried out with compounds 29 (L. infantum IC50: 4.1 μM) and 39 (L. infantum IC50: 0.5 μM) in an acute L. infantum VL mouse model, which showed problems of poor exposure and lack of efficacy, despite the good in vitro potency.
- Ferreira, Rafael Augusto Alves,Junior, Celso de Oliveira Rezende,Martinez, Pablo David Grigol,Koovits, Paul John,Soares, Bruna Miranda,Ferreira, Leonardo L. G.,Michelan-Duarte, Simone,Chelucci, Rafael Consolin,Andricopulo, Adriano D.,Galuppo, Mariana K.,Uliana, Silvia R. B.,Matheeussen, An,Caljon, Guy,Maes, Louis,Campbell, Simon,Kratz, Jadel M.,Mowbray, Charles E.,Dias, Luiz Carlos
-
-
- STING AGONISTS AND USES THEREOF
-
The present invention provides compounds, compositions thereof, and methods of using the same for the modulation of STING, and the treatment of STING-mediated disorders.
- -
-
Paragraph 00616
(2020/07/14)
-
- Structure-activity relationship studies of antiplasmodial cyclometallated ruthenium(II), rhodium(III) and iridium(III) complexes of 2-phenylbenzimidazoles
-
Benzimidazoles, such as albendazole, thiabendazole and omeprazole have antiplasmodial activity against Plasmodium falciparum and are widely used as scaffolds for metal-based drug research. Incorporating substituents with various lipophilic and electronic
- Rylands, Laa-iqa,Welsh, Athi,Maepa, Keletso,Stringer, Tameryn,Taylor, Dale,Chibale, Kelly,Smith, Gregory S.
-
-
- METALLOENZYME INHIBITOR COMPOUNDS
-
Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
- -
-
Paragraph 1590; 1594
(2018/07/29)
-
- Novel benzimidazolyl tetrahydroprotoberberines: Design, synthesis, antimicrobial evaluation and multi-targeting exploration
-
A series of novel benzimidazolyl tetrahydroprotoberberines were conveniently designed and efficiently synthesized from berberine via direct cyclization of tetrahydroprotoberberine aldehyde and o-phenylene diamines under metal-free aerobic oxidation. All the new compounds were characterized by IR, 1H NMR, 13C NMR and HRMS spectra. The antimicrobial evaluation revealed that the 5-fluorobenzimidazolyl derivative 5b was the most active antibacterial and antifungal molecule with broad spectrum in comparison to Berberine, Chloromycin, Norfloxacin and Fluconazole. It triggered almost no resistance development against MRSA even after 15 passages. Further studies demonstrated that compound 5b could not only effectively interact with Topo IA by hydrogen bonds, but also intercalate into calf thymus DNA and cleave pBR322 DNA, which might be responsible for its powerful bioactivities.
- Jeyakkumar, Ponmani,Liu, Han-Bo,Gopala, Lavanya,Cheng, Yu,Peng, Xin-Mei,Geng, Rong-Xia,Zhou, Cheng-He
-
p. 1737 - 1743
(2017/04/04)
-
- Design, synthesis and biological evaluation of 5-fluorouracil-derived benzimidazoles as novel type of potential antimicrobial agents
-
A series of 5-fluorouracil benzimidazoles as novel type of potential antimicrobial agents were designed and synthesized for the first time. Bioactive assay manifested that some of the prepared compounds exhibited good or even stronger antibacterial and an
- Fang, Xue-Jie,Jeyakkumar, Ponmani,Avula, Srinivasa Rao,Zhou, Qian,Zhou, Cheng-He
-
p. 2584 - 2588
(2016/05/09)
-
- Discovery of membrane active benzimidazole quinolones-based topoisomerase inhibitors as potential DNA-binding antimicrobial agents
-
A series of novel benzimidazole quinolones as potential antimicrobial agents were designed and synthesized. Most of the prepared compounds exhibited good or even stronger antimicrobial activities in comparison with reference drugs. The most potent compound 15m was membrane active and did not trigger the development of resistance in bacteria. It not only inhibited the formation of biofilms but also disrupted the established Staphylococcus aureus and Escherichia coli biofilms. It was able to inhibit the relaxation activity of E. coli topoisomerase IV at 10 μM concentration. Moreover, this compound also showed low toxicity against mammalian cells. Molecular modeling and experimental investigation of compound 15m with DNA suggested that this compound could effectively bind with DNA to form a steady 15m-DNA complex which might further block DNA replication to exert the powerful bioactivities.
- Zhang, Ling,Addla, Dinesh,Ponmani, Jeyakkumar,Wang, Ao,Xie, Dan,Wang, Ya-Nan,Zhang, Shao-Lin,Geng, Rong-Xia,Cai, Gui-Xin,Zhou, Cheng-He,Li, Shuo
-
p. 160 - 182
(2018/05/17)
-
- Imidoyl dichlorides as new reagents for the rapid formation of 2-aminobenzimidazoles and related azoles
-
The development of a reagent for the efficient synthesis of five- and six-membered azoles at room temperature is proposed. A variety of substituted 2-aminobenzimidazoles are synthesized in good to excellent yields. The ability to incorporate various protecting groups makes the imidoyl dichloride reagent amenable to a large number of syntheses. The reagent is applied to the total synthesis of the 2-aminobenzimidazole containing carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), from 2-chloro-3-nitropyridine in >60% yield in 6 steps.
- Pollock, Julie A.,Kim, Sung Hoon,Katzenellenbogen, John A.
-
p. 6097 - 6099
(2015/10/28)
-
- Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[ a[phenazin derivatives as dual topoisomerase I/II inhibitors
-
A novel series of benzo[a]phenazin derivatives bearing alkylamino side chains were designed, synthesized and evaluated for their topoisomerases inhibitory activity as well as cytotoxicity against four human cancer cell lines (HL-60, K-562, HeLa, and A549)
- Yao, Bing-Lei,Mai, Yan-Wen,Chen, Shuo-Bin,Xie, Hua-Ting,Yao, Pei-Fen,Ou, Tian-Miao,Tan, Jia-Heng,Wang, Hong-Gen,Li, Ding,Huang, Shi-Liang,Gu, Lian-Quan,Huang, Zhi-Shu
-
p. 540 - 553
(2015/01/30)
-
- Design, synthesis and biological evaluation of benzimidazole-pyridine-piperidine hybrids as a new class of potent antimicrobial agents
-
A series of novel benzimidazole-pyridine-piperidine hybrids was synthesized in good yields and characterized by spectral and elemental analyses. The compounds 4a-h and 5a-c were evaluated for their in vitro antibacterial activity against gram-positive org
- Beulah, KothapallY.,Kumar, Akula Ravi,Lingaiah, Boddupally Peda Venkat,Rao, Pamulaparthy Shanthan,Narsaiah, Banda,Reddy, Aaramadaka Sunil Kumar,Murty, Upadhyayula Surya Narayana
-
-
- Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesis
-
This article describes discovery of a novel and new class of cholinesterase inhibitors as potential therapeutics for Alzheimer's disease. A series of novel isoalloxazine derivatives were synthesized and biologically evaluated for their potential inhibitory outcome for both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). These compounds exhibited high activity against both the enzymes AChE as well as BuChE. Of the synthesized compounds, the most potent isoalloxazine derivatives (7m and 7q) showed IC50 values of 4.72 μM and 5.22 μM respectively against AChE; and, 6.98 μM and 5.29 μM respectively against BuChE. These two compounds were further evaluated for their anti-aggregatory activity for β-amyloid (Aβ) in presence and absence of AChE by performing Thioflavin-T (ThT) assay and Congo red (CR) binding assay. In order to evaluate cytotoxic profile of these two potential compounds, cell viability assay of SH-SY5Y human neuroblastoma cells was performed. Further, to understand the binding behavior of these two compounds with AChE and BuChE enzymes, docking studies have been reported.
- Kanhed, Ashish M.,Sinha, Anshuman,Machhi, Jatin,Tripathi, Ashutosh,Parikh, Zalak S.,Pillai, Prakash P.,Giridhar, Rajani,Yadav, Mange Ram
-
-
- 1- Or 3-(3-amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2- ones: Potent, selective, and orally efficacious norepinephrine reuptake inhibitors
-
Sequential structural modifications of the aryloxypropanamine template (e.g., atomoxetine, 2) led to a novel series of 1-(3-amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors (NRIs). In general, this series of compounds potently blocked the human norepinephrine transporter (hNET) while exhibiting selectivity at hNET against both the human serotonin (hSERT) and dopamine transporters (hDAT). Numerous compounds (e.g., 19-22) had low nonamolar hNET potency with IC 50 values of 7-10 nM and excellent selectivity (>500 fold) at hNET over hSERT and hDAT. Several compounds, such as 20 and 22, were tested in a telemetric rat model of ovariectomized-induced thermoregulatory dysfunction and were efficacious at oral doses of 3 mg/kg in reducing the tail skin temperature. In addition, compound 20 was also studied in the rat hot plate and spinal nerve ligation (SNL) models of acute and neuropathic pain, respectively, and was orally efficacious at doses of 3-10 mg/kg.
- Zhang, Puwen,Terefenko, Eugene A.,Bray, Jenifer,Deecher, Darlene,Fensome, Andrew,Harrison, Jim,Kim, Callain,Koury, Elizabeth,Mark, Lilly,McComas, Casey C.,Mugford, Cheryl A.,Trybulski, Eugene J.,Vu, An T.,Whiteside, Garth T.,Mahaney, Paige E.
-
experimental part
p. 5703 - 5711
(2010/02/28)
-
- Benzimidazolium-pyrazole-palladium(II) complexes: New and efficient catalysts for Suzuki, Heck and Sonogashira reactions
-
Three unsymmetrical benzimidazoliumpyrazole N-N ligands 2-(1-propylbenzimidazolylmethyl)-3,5-di-R-pyrazole (R=H, Me, t-Bu) have been conveniently prepared and structurally analyzed. The solid lattice packingof the R=Me compound at 223 K reveals one-dimensional "zig-zag" water chains stabilized by organic molecular channels through N...H-O and O-H...O bonding. These hybrid ligands add to palladium(II) to give high yields of air-stable complexes that are fully characterized by NMR, ESI, and X-ray single-crystal crystallography. They are active Suzuki catalysts at room temperature towards cross-couplingof unactivated aryl bromides and 5- or 6-membered heteroaryl bromides with arylboronic acids with turnover frequencies (TOF) reachingas high as 60,000 h-1. Their catalytic efficiency is significantly better than that of the C-N carbene-imidazole analogue. These catalysts are also active in Heck and Sonogashira cross-coupling reactions of aryl bromides giving the desired products in good yields. These results suggested that these Pd(II) complexes with N-based hybrid ligands are versatile and efficient catalysts for different types of cross-couplingreactio ns under aerobic conditions.
- Li, Fuwei,Hor, T. S. Andy
-
scheme or table
p. 2391 - 2400
(2009/10/08)
-
- Lead identification of 2-iminobenzimidazole antagonists of the chemokine receptor CXCR3
-
Modification of a 2-iminobenzimidazole series derived from an HTS hit resulted in compounds with improved in-vitro species selectivity. Incorporation of an 8-quinoline amide and conformational rigidification of an aliphatic tether furnished potent compounds suitable for further lead optimization.
- Hayes, Martin E.,Breinlinger, Eric C.,Wallace, Grier A.,Grongsaard, Pintipa,Miao, Wenyan,McPherson, Michael J.,Stoffel, Robert H.,Green, David W.,Roth, Gregory P.
-
p. 2414 - 2419
(2008/09/20)
-
- High-pressure alkylation of bis(benzylidene)phenylenediamines
-
The reactions of alkyl chlorides with bisanils (obtained from o-, m-, and p-phenylenediamines) under high pressure (10 kbar) were studied. Depending on the structure of the starting diamines and the solvent nature, hydrolysis of the reaction mixtures gave
- Agafonov,Dudin,Preobrazhenskii,Zhulin
-
p. 273 - 275
(2007/10/03)
-
- A NEW ROUTE TO N-ALKYL-o-PHENYLENEDIAMINES UTILISING N-ALKYL-2,1,3-BENZOTHIADIAZOLIUM SALTS AND THEIR SELENIUM ANALOGUES
-
The alkyl quaternary salts of 2,1,3-benzothiadiazole and 2,1,3-benzoselenadiazole undergo facile ring-opening to produce the corresponding N-alkyl-o-phenylenediamines.
- Ralph, J. T.
-
p. 1381 - 1388
(2007/10/02)
-
- Pyrimidobenzodiazepinones, their use and medicaments containing them
-
11-Acyl-2-phenyl- and 11-acyl-5,6-dihydropyrimido[4,5-b][1,5]benzodiazepin-5-ones, their acid-addition salts and their N-oxides provide protective action for the stomach and intestines of warm-blooded animals and inhibit the formation of gastric and intestinal ulcers.
- -
-
-